A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

A new lipid nanoparticle could make mRNA vaccines more powerful and potentially lower the cost per vaccine dose.

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected revenue range to $1.6 – $2.0 billion Improves 2025 expected GAAP operating ...

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for ...

The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...

A new lipid nanoparticle could make mRNA vaccines more effective and potentially lower the cost per dose. New research suggests an mRNA influenza vaccine delivered with the new particle could generate ...

Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

A senior biosecurity adviser at the U.S. Department of Health and Human Services, who has made several critical statements ...

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: A precisely timed mRNA shot could help many cancer patients live longer.

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for certain skin and lung cancers.